RAFAEL
SEGARRA ECHEVARRIA
PROFESORADO ASOCIADO
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Institut d'Investigacions Biomèdiques August Pi i Sunyer (7)
2024
-
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis
Therapeutic Advances in Psychopharmacology, Vol. 14
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
2019
-
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794
-
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105
2018
-
Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis
Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455
-
Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study
European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711
2017
-
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study
Schizophrenia Research, Vol. 189, pp. 84-90